Harbor Investment Advisory, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Harbor Investment Advisory, LLC

$1.19 Billion
Q3 2024

A detailed history of Harbor Investment Advisory, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 3,664 shares of REGN stock, worth $2.71 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

3,664

Previous 3,764 2.66%

Holding current value

$2.71 Million

Previous $3.96 Million 2.65%

% of portfolio

0.32%

Previous 0.35%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$1024.09 - $1201.76 $102,408 - $120,176	-100 Reduced 2.66%	3,664 $3.85 Million
Q2 2024 Jul 19, 2024	BUY	$883.2 - $1071.19 $49,459 - $59,986	56 Added 1.51%	3,764 $3.96 Million
Q1 2024 Apr 12, 2024	BUY	$902.69 - $993.35 $31,594 - $34,767	35 Added 0.95%	3,708 $3.57 Million
Q4 2023 Jan 26, 2024	BUY	$775.18 - $881.7 $38,759 - $44,085	50 Added 1.38%	3,673 $3.23 Million
Q3 2023 Oct 13, 2023	SELL	$692.45 - $844.37 $3,462 - $4,221	-5 Reduced 0.14%	3,623 $2.98 Million
Q1 2023 Apr 21, 2023	SELL	$680.49 - $826.97 $272,196 - $330,788	-400 Reduced 9.93%	3,628 $2.98 Million
Q4 2022 Jan 24, 2023	SELL	$705.89 - $766.39 $35,294 - $38,319	-50 Reduced 1.23%	4,028 $0
Q3 2022 Nov 01, 2022	SELL	$573.97 - $724.32 $179,652 - $226,712	-313 Reduced 7.13%	4,078 $2.81 Million
Q2 2022 Jul 18, 2022	SELL	$548.35 - $738.84 $188,632 - $254,160	-344 Reduced 7.27%	4,391 $2.6 Million
Q1 2022 Apr 20, 2022	BUY	$595.12 - $698.43 $66,653 - $78,224	112 Added 2.42%	4,735 $3.31 Million
Q4 2021 Jan 10, 2022	SELL	$543.48 - $670.97 $144,565 - $178,478	-266 Reduced 5.44%	4,623 $2.92 Million
Q3 2021 Oct 12, 2021	BUY	$574.03 - $680.96 $83,234 - $98,739	145 Added 3.06%	4,889 $2.96 Million
Q2 2021 Jul 27, 2021	BUY	$472.8 - $558.54 $243,964 - $288,206	516 Added 12.2%	4,744 $2.65 Million
Q1 2021 Apr 16, 2021	BUY	$446.73 - $548.2 $205,495 - $252,172	460 Added 12.21%	4,228 $2 Million
Q4 2020 Feb 04, 2021	BUY	$478.3 - $607.98 $1.35 Million - $1.72 Million	2,823 Added 298.73%	3,768 $1.82 Million
Q3 2020 Oct 23, 2020	BUY	$544.75 - $658.21 $64,825 - $78,326	119 Added 14.41%	945 $529,000
Q2 2020 Jul 16, 2020	BUY	$493.32 - $643.92 $11,839 - $15,454	24 Added 2.99%	826 $515,000
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $29,247 - $43,015	87 Added 12.17%	802 $392,000
Q4 2019 Jan 16, 2020	BUY	$274.13 - $376.51 $196,002 - $269,204	715 New	715 $268,000

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.

Account

Harbor Investment Advisory, LLC Regeneron Pharmaceuticals, Inc. Transaction History